Analysis and Evolution of Profitability in the Pharmaceutical Field in Romania

Izabela Diana Hada ()
Additional contact information
Izabela Diana Hada: Ph.D. Student, „1 Decembrie 1918†University of Alba Iulia, România

Chapter 55 in International Conference Innovative Business Management & Global Entrepreneurship (IBMAGE 2020), 2020, vol. 14, pp 744-757 from Editura Lumen

Abstract: The pharmaceutical industry is an important field of activity that contributes to the diagnosis, treatment, maintenance of the health of the population. The need of pharmaceuticals has led to an increase in both the number of drug manufacturers and the number of distributors. A significant part of the specialized studies deals with the problem of the profitability of the pharmaceutical industry. The study of the financial performance of the economic entities in the pharmaceutical field in Romania is a necessary concern in the conditions of a progressive annual increase of the profitability of this sector. The main purpose of this paper is the analysis and presentation of the evolution of profitability indicators (return on assets, return on capital, return on sales) as part of the activity of assessing the financial performance of economic entities operating in Romania in the pharmaceutical industry (manufacturing of basic pharmaceutical products - CAEN code 2110). Profitability indicators were analyzed for a number of 46 entities in the pharmaceutical industry in Romania for a period of 20 years (1999-2018). We are talking in this case about a turnover of 1.1 Billion lei (249.2 million euros), a number of employees of 3,098 employees, a profit of 135.2 million lei (30.7 million euros) - representing 0.12% of the net profit made in Romania. The research results show that in the period 2008-2009, the financial crisis left a strong mark on the evolution of profitability in the pharmaceutical industry. However, during the 20 years we talk about a positive evolution, in the sense of increasing the profitability of this field, which justifies the increase in the consumption of pharmaceuticals products.

Keywords: financial performance; ROA; ROE; return on sales (ROS); pharmaceutical field (search for similar items in EconPapers)
JEL-codes: F2 M1 M2 O1 O3 Q5 (search for similar items in EconPapers)
Date: 2020
ISBN: 978-1-910129-29-6
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://proceedings.lumenpublishing.com/ojs/index. ... article/view/605/605 (application/pdf)
https://proceedings.lumenpublishing.com/ojs/index. ... ngs/article/view/605 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:lum:prchap:14-55

DOI: 10.18662/lumproc/ibmage2020/55

Access Statistics for this chapter

More chapters in Book chapters-LUMEN Proceedings from Editura Lumen
Bibliographic data for series maintained by Antonio Sandu ().